Testing effectiveness (Phase 2)Study completedNCT01523821
What this trial is testing
Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)
Who this might be right for
Graft-Versus-Host Disease (GVHD) Acute on Chronic
Fred Hutchinson Cancer Center 20